Pleuropulmonary Blastoma in Pediatric Lung Lesions
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Mar 2021 · 1 min read
In brief
In brief
Multi-institutional study of 521 pediatric lung lesions reveals that prenatally diagnosed lesions showed no malignancy, while 8.7% of postnatally detected lesions were malignant, predominantly pleuropulmonary blastoma with DICER1 mutations. Preoperative CT had low sensitivity (33%) for detecting malignancy, but increased radiologic suspicion and bilateral disease were strong predictors of malignant pathology.
Written by the GCMD Library team from the article.
Statements in this article
None of 344 prenatally diagnosed lung lesions had malignant pathology.
Among 177 children without prenatal detection, 15 (8.7%) had malignant tumors including type 1 pleuropulmonary blastoma (n=11), other pleuropulmonary blastoma (n=3), and adenocarcinoma (n=1).
Malignant lung lesions in children without prenatal detection were diagnosed at a median age of 20.7 months (interquartile range 7.9-58.1 months).
DICER1 mutation was associated with malignancy in 8 of 14 (57%) pleuropulmonary blastoma cases.
No malignant lung lesion had a systemic feeding vessel.
Preoperative chest CT has a sensitivity of 33.3% (95% CI 15.2-58.3%) for detecting malignant pathology in pediatric lung lesions.
Increased suspicion of malignancy on CT is a significant predictor of malignant pathology with an odds ratio of 42.15 (95% CI 7.43-340.3).
Bilateral lung disease is a significant predictor of malignant pathology with an odds ratio of 42.03.
